Loss of cyclin-dependent kinase inhibitor p27(Kip1) is a novel prognostic factor in localized human prostate adenocarcinoma

John Tsihlias, Linda R. Kapusta, Gerrit DeBoer, Izabella Morava-Protzner, Ingrid Zbieranowski, Nandita Bhattacharya, G. Charles Catzavelos, Laurence H. Klotz, Joyce M. Slingerland

Research output: Contribution to journalArticlepeer-review

304 Scopus citations

Fingerprint

Dive into the research topics of 'Loss of cyclin-dependent kinase inhibitor p27(Kip1) is a novel prognostic factor in localized human prostate adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences